Piribedil

Generic Name
Piribedil
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C16H18N4O2
CAS Number
3605-01-4
Unique Ingredient Identifier
DO22K1PRDJ
Background

Piribedil has been investigated in Parkinson's Disease.

Indication

适用于治疗帕金森病和帕金森综合症，对震颤作用强，对强直和少动的作用较弱。亦可用于老年患者的慢性病理性认知和感觉神经障碍的辅助性症状性治疗，下肢慢性阻塞性动脉病所致的间歇性跛行的辅助性治疗。

Associated Conditions
Parkinson's Disease (PD)
Associated Therapies
-
Clinical Trials
Related News

Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists

First Posted Date
2009-11-04
Last Posted Date
2012-05-24
Lead Sponsor
Desitin Arzneimittel GmbH
Target Recruit Count
80
Registration Number
NCT01007864

SEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson's Disease (PIR-002/K)

Completed
Conditions
Parkinson's Disease
Interventions
Drug: Piribedil
First Posted Date
2008-08-04
Last Posted Date
2009-02-25
Lead Sponsor
Desitin Arzneimittel GmbH
Target Recruit Count
750
Registration Number
NCT00727727
Locations
🇩🇪

Medical Practice for Neurology, Wedel, Germany

SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease

Completed
Conditions
Parkinson's Disease
First Posted Date
2008-07-30
Last Posted Date
2010-03-31
Lead Sponsor
Desitin Arzneimittel GmbH
Target Recruit Count
250
Registration Number
NCT00725478

Tinnitus Treatment With Piribedil Guided by Acoustic Otoemissions and Electrocochleography

Not Applicable
Completed
Conditions
Tinnitus
First Posted Date
2008-01-11
Last Posted Date
2008-03-07
Lead Sponsor
Faculdade de Medicina de Valenca
Target Recruit Count
100
Registration Number
NCT00591994
Locations
🇧🇷

OTOSUL,Otorrinolaringologia Sul-Fluminense, Volta Redonda, RJ, Brazil

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy